Earn rewards for your opinion on lab products.
Get exclusive insights into life science trends.
Stay up to date on research news.
How one CDMO is navigating the global supply chain disruption
June 24, 2022 -- The COVID-19 pandemic has disrupted supply chains and production schedules around the world, forcing contract development and manufacturing organizations (CDMOs) to adapt. In a video interview at the 2022 Biotechnology Innovation Organization International Convention, Federico Pollano of Rentschler Biopharma discussed how the company is navigating the worldwide supply chain disruption. Read More
A case study on partnering between patient advocacy organizations and biotech
June 23, 2022 -- Last week's 2022 Biotechnology Innovation Organization (BIO) International Convention in San Diego gave patient advocacy organizations and biotech companies the first opportunity in three years to meet in person with the potential for partnering. However, it was a meeting at BIO 2019 between CMT Research Foundation and DTx Pharma that could serve as a model for such partnerships. Read More
NIH seeks industry partners for technology transfer
June 23, 2022 -- The National Institutes of Health (NIH) is the world’s largest public funder of biomedical research. ScienceBoard.net spoke with Michael Salgaller of the National Cancer Institute at the 2022 Biotechnology Innovation Organization International Convention about NIH’s technology transfer professionals who work with its scientist inventors to find commercial partners to take their inventions to market. Read More
Estonia’s ambitious plans to grow its biotech industry
June 22, 2022 -- The Baltic state of Estonia's biotech industry is expected to grow tenfold this decade and offers significant opportunities for Estonian companies. ScienceBoard.net spoke with Andres Sutt, Estonia’s minister of entrepreneurship and information technology, at the 2022 Biotechnology Innovation Organization International Convention in San Diego about the country’s ambitious plans to grow its biotech industry. Read More
Fauna Bio leverages animal genomics, hibernation biology to target human diseases
June 21, 2022 -- Biotech company Fauna Bio is leveraging animal genomics and hibernation biology to develop novel translational therapeutics for disease prevention and reduce the impact of age-related diseases in humans. ScienceBoard.net spoke with co-founder and CEO Ashley Zehnder about the intersection of animal genomics, hibernation biology, and human diseases. Read More
Using the power of plants to develop novel biopharmaceuticals
June 21, 2022 -- Biologics manufacturing company iBio is using plants as bioreactors to develop and manufacture therapeutics and vaccines. ScienceBoard.net spoke with CEO Tom Isett at the 2022 Biotechnology Innovation Organization International Convention about the company’s technology, programs, and more. Read More
Apeiron Biologics' spinout invIOs targets solid tumors with novel cell therapy platform
June 20, 2022 -- Apeiron Biologics' spinout invIOs has a proprietary cell therapy platform for the modulation of intracellular immuno-oncology targets that enables rapid treatment of cancer patients using their own immune cells with short out-of-body time in out-patient settings. ScienceBoard.net spoke with invIOs’ CEO Peter Llewellyn-Davies at the 2022 Biotechnology Innovation Organization International Convention in San Diego. Read More
Overcoming the challenges of off-the-shelf allogeneic cell therapies
June 20, 2022 -- Chimeric antigen receptor T-cell therapy has emerged as one of the major breakthroughs in cancer immunotherapy in the last decade. In a video interview at the 2022 Biotechnology Innovation Organization International Convention in San Diego, Dr. Jason Litten discussed the challenges that need to be overcome for allogeneic T cells to reach clinical success. Read More
Struggle to include women in clinical trials continues despite gains
June 16, 2022 -- Though female participation in clinical trials has been steadily improving over the years, most of the women enrolled in trials are white and not members of minority groups. ScienceBoard.net spoke with Kathryn Schubert, president and CEO of the Society for Women's Health Research, about inclusivity in clinical trials at the 2022 Biotechnology Innovation Organization International Convention in San Diego. Read More
Life sciences industry’s search for talent is becoming more challenging: study
June 15, 2022 -- While more professionals are engaged in life sciences research in the U.S. and a record number of people are graduating in the biological and biomedical sciences, the ability of employers to find life sciences research talent is proving extremely difficult, according to a new report from CBRE. Read More
Patient advocacy organizations look to partner with pharma companies
June 14, 2022 -- Patient advocacy organizations are looking to partner with pharmaceutical companies, offering resources and expertise to maximize the impact and efficiency of their therapeutic R&D programs. It’s a message that these groups want to drive home to pharma at the 2022 Biotechnology Innovation Organization International Convention in San Diego. Read More
How to develop a sustainable portfolio for cell, gene therapy platforms
June 13, 2022 -- Michael Retterath, a Biotechnology Innovation Organization International Convention 2022 panelist and chief business officer at Spark Therapeutics, spoke to ScienceBoard.net about his company’s transition from a research center to a private, venture-backed startup and a publicly traded company. Read More
Biotech industry execs, not scientists, remain male-dominated
June 13, 2022 -- A panel at the 2022 Biotechnology Innovation Organization International Convention will explore how to close the gender gap in the biotech industry and how it can become more inclusive. ScienceBoard.net spoke with Nasha Fitter, co-founder and CEO of the FOXG1 Research Foundation, who will participate in the June 14 panel at the convention. Read More
The ‘voice of the patient’ needs to be heard in clinical trials: study
June 10, 2022 -- Patient recruitment and retention are among the biggest challenges facing clinical research, particularly in studies targeting rare diseases that have a limited pool of patients, contends Clincierge CEO Scott Gray. He spoke with ScienceBoard.net about Clincierge's study examining the patient experience in clinical trials of rare diseases. Read More
New era of non-viral DNA-delivered gene therapy seen emerging
June 9, 2022 -- Advancements in nucleic acid-encoded therapeutics over the past decade have sparked the emergence of a new era in non-viral DNA-delivered gene therapy, according to Xalud Therapeutics CEO Diem Nguyen, PhD. Read More
Science In Brief
Conferences
Microscopy and Microanalysis Meeting
July 31 - August 4
Portland, Oregon United States
July 31 - August 4
Portland, Oregon United States
Glasgow International Health Festival
August 24-27
Glasgow, Glasgow City United Kingdom
August 24-27
Glasgow, Glasgow City United Kingdom
Sales and Marketing Professionals in Science Annual Meeting
September 1
United States
September 1
United States
Pharma Competitive Intelligence Conference and Exhibition
September 21-22
Newark, New Jersey United States
September 21-22
Newark, New Jersey United States
BioProcess International (BPI) Conference
September 27-30
Boston, Massachusetts United States
September 27-30
Boston, Massachusetts United States
Connect
Latest Tweets